Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Authors :: Jacob D. Soumerai
Allison Rosenthal
Shannon Harkins
Jessica Duffy
Carmen Mecca
Yingbing Wang
Ravinder K. Grewal
Areej R. El-Jawahri
Huiyun Liu
Cedric Menard
Ahmet Dogan
Lei Yang
Lisa M. Rimsza
Kurt Bantilan
Haley Martin
Matthew Lei
Sydney Mohr
Anna Kurilovich
Olga Kudryashova
Ekaterina Postovalova
Valentina Nardi
Jeremy S. Abramson
Roberto Chiarle
Andrew D. Zelenetz
Abner Louissaint
Source :: Blood. 140:1822-1826
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Subjects :: Lymphoma, B-Cell
Lung Neoplasms
Immunology
Humans
Anaplastic Lymphoma Kinase
Cell Biology
Hematology
Protein Kinase Inhibitors
Biochemistry

Tools